KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Other Working Capital Changes: 2009-2024

Historic Other Working Capital Changes for Rigel Pharmaceuticals (RIGL) over the last 16 years, with Dec 2024 value amounting to $3.4 million.

  • Rigel Pharmaceuticals' Other Working Capital Changes rose 34.10% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.4 million, marking a year-over-year increase of 24.53%. This contributed to the annual value of $3.4 million for FY2024, which is 267.48% up from last year.
  • Latest data reveals that Rigel Pharmaceuticals reported Other Working Capital Changes of $3.4 million as of FY2024, which was up 267.48% from -$2.1 million recorded in FY2023.
  • In the past 5 years, Rigel Pharmaceuticals' Other Working Capital Changes registered a high of $3.4 million during FY2024, and its lowest value of -$23.6 million during FY2020.
  • In the last 3 years, Rigel Pharmaceuticals' Other Working Capital Changes had a median value of -$2.1 million in 2023 and averaged -$2.4 million.
  • Per our database at Business Quant, Rigel Pharmaceuticals' Other Working Capital Changes crashed by 197.42% in 2020 and then spiked by 267.48% in 2024.
  • Rigel Pharmaceuticals' Other Working Capital Changes (Yearly) stood at -$23.6 million in 2020, then skyrocketed by 63.52% to -$8.6 million in 2021, then rose by 0.87% to -$8.5 million in 2022, then spiked by 75.97% to -$2.1 million in 2023, then spiked by 267.48% to $3.4 million in 2024.